Sentinel hospital-based surveillance of Rotavirus diarrhea in Iran

Journal of Infectious Diseases

Volumn 200, Issue SUPPL. 1, 2009, Pages

  Eesteghamati, A ^a   Gouya, M ^a   Keshtkar, A ^c   Najafi, L ^c   Zali, M R ^b   Sanaei, M ^b   Yaghini, F ^a   El Mohamady, H ^d   Patel, M ^f   Klena, J D ^d   Teleb, N ^e  

^a MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d US Naval Medical Research Unit No 3 Egypt   (Egypt)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GASTROENTERITIS; ARTICLE; CHILD; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FECES ANALYSIS; GENOTYPE; HEALTH SURVEY; HUMAN; INFANT; INFECTIOUS DIARRHEA; IRAN; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; VIRUS DETECTION; VIRUS TYPING;

CHILD, PRESCHOOL; COST OF ILLNESS; DIARRHEA; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; IRAN; ROTAVIRUS; ROTAVIRUS INFECTIONS;

EID: 72849144318     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605050     Document Type: Article

References (20)

1. World Health Organization. Estimated rotavirus deaths for children under 5 years of age: 2004, 527 000. Geneva: World Health Organization March 2006. Available at: http://www.who.int/immunization-monitoring/burden/rotavirus- estimates/en/. Accessed 16 June 2008.
2. Bresee JS, Hummelman E, Nelson EA, Glass RI. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis 2005; 192(Suppl 1):S1-5.
3. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12:304-306
4. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565-572
5. Bresee JS, Parashar UD, Widdowson MA, Gentsch JR, Steele AD, Glass RI. Update on rotavirus vaccines. Pediatr Infect Dis J 2005; 24:947-952
6. Glass RI, Parashar UD, Bresee JS, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006; 368:323-332 (Pubitemid 44067224) (Pubitemid 44067224)
7. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 2007; 82:285-295
8. World Health Organization. Generic protocols for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. Document WHO/V&B/02.15. Geneva: World Health Organization, 2002:1-67.
9. Das BK, Gentsch JR, Cicirello HG, et al. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol 1994; 32:1820-1822
10. Gentsch JR, Glass RI,Woods P, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992; 30: 1365-1373
11. Amini S, Solati AA, Fayaz A, Mahmoodi M. Rotavirus infection in children with acute diarrhea in Tehran. Med J Islam Repub Iran 1990;4: 25-28
12. Cook SM, Glass RI, LeBaron CW, Ho MS. Global seasonality of rotavirus infections. Bull World Health Organ 1990; 68:171-177
13. Diekmann O. Thresholds and travelling waves for the geographical spread of infection. J Math Biol 1978; 6:109-130 (Pubitemid 8406817)
14. Solberg OD, Hasing ME, Trueba G, Eisenberg JN. Characterization of novel VP7, VP4, and VP6 genotypes of a previously untypeable group A rotavirus. Virology 2009; 385:58-67.
15. Zade JK, Chhabra P, Chitambar SD. Characterization of VP7 and VP4 genes of rotavirus strains: 1990-1994 and 2000-2002. Epidemiol Infect 2009; 137:936-942
16. Centers for Disease Control and Prevention. Delayed onset and diminished magnitude of rotavirus activity-United States, November 2007-May 2008. MMWR Morb Mortal Wkly Rep 2008; 57:697-700.
17. Linhares AC, Velazquez FR, Perez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371:1181-1189
18. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22. (Pubitemid 43048947) (Pubitemid 43048947)
19. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-1763 (Pubitemid 350137490) (Pubitemid 350137490)
20. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33. (Pubitemid 43048948) (Pubitemid 43048948)